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Abstract
Objectives The 22 countries of the East Mediterranean
Region (EMR) have large populations of adolescents aged
10–24 years. These adolescents are central to assuring the
health, development, and peace of this region. We descri-
bed their health needs.
Methods Using data from the Global Burden of Disease
Study 2015 (GBD 2015), we report the leading causes of
mortality and morbidity for adolescents in the EMR from
1990 to 2015. We also report the prevalence of key health
risk behaviors and determinants.
Results Communicable diseases and the health consequences
of natural disasters reduced substantially between 1990 and
2015. However, these gains have largely been offset by the
health impacts of war and the emergence of non-communi-
cable diseases (including mental health disorders), uninten-
tional injury, and self-harm. Tobacco smoking and high body
mass were common health risks amongst adolescents. Addi-
tionally, many EMR countries had high rates of adolescent
pregnancy and unmet need for contraception.
Conclusions Even with the return of peace and security,
adolescents will have a persisting poor health profile that
will pose a barrier to socioeconomic growth and develop-
ment of the EMR.
Keywords Adolescent health  Burden of disease  Eastern
Mediterranean Region
Introduction
The World Health Organization’s Eastern Mediterranean
Region (EMR) is an administrative region of 22 countries
(Table 1) that while rich in natural resources, has marked
country-level variation in socioeconomic wealth (ranging
from $US 549.3 per capita in Somalia to $US 73,653.4 per
capita in Qatar), health system capacities and health cov-
erage (Blair et al. 2014; Mandil et al. 2013; WHO 2017b).
Many countries in the EMR have recently experienced
social and political instabilities, civil unrest, war, and mass
displacement of people (Mokdad et al. 2016a). As a result,
health in many EMR countries has failed to improve in
recent years (Mokdad et al. 2016a, 2014). As other papers
in this series highlight, there is now an increasing burden of
many preventable health problems including HIV, mental
health disorders, and intentional injury (GBD 2015 Eastern
Mediterranean Region HIV/AIDS Collaborators and
Mokdad 2017; GBD 2015 Eastern Mediterranean Region
Intentional Injuries Collaborators and Mokdad 2017; GBD
2015 Eastern Mediterranean Region Mental Health Col-
laborators and Mokdad 2017). There is a risk that without
urgent action, the health status of this region will only
deteriorate further, with both regional and global conse-
quences for health, social stability, and economic
development.
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Adolescence is increasingly understood as a key devel-
opmental stage for assuring health across the course of
one’s life, and as such, provides significant opportunities to
improve population health in the EMR (Patton et al. 2016;
The World Bank 2006). Firstly, adolescents represent more
than a quarter of the population in the EMR, and their
health needs are likely to be distinct from children and
adults. Conflict and civil unrest (which have been a feature
of many countries in the EMR) have a large impact on the
health of young people, both acutely (through high rates of
mortality and morbidity due to violence) but also in the
longer term (including mental health disorder and poor
sexual and reproductive health) (Viner et al. 2012). Sec-
ondly, many health risks typically emerge during adoles-
cence including those for non-communicable diseases
(NCDs) such as substance use, overweight, and physical
inactivity. Given that NCDs are now the leading cause of
poor health in the EMR, there is a potential to intervene
before harms arise (Mokdad et al. 2016b). Thirdly, ado-
lescents are critical to driving socioeconomic development
(The World Bank 2006). Poor physical health and mental
health are barriers to participation in education and
employment, as are policies and systems that do not enable
equitable access. Finally, in their role as current and future
parents, the health of adolescents has significant implica-
tions for the next generation (Patton et al. 2016).
To date, the health problems and health risks of ado-
lescents in the EMR have been inadequately described
(Alaovie et al. 2017). This is a significant barrier to
developing comprehensive policies that address adolescent
health and to measuring the impact of any investments
made. This paper aims to report the health profile for
adolescents living in the EMR.
Methods
We framed our study around the conceptual framework
defined by the Lancet Commission of Adolescent Health
and Wellbeing (hereafter referred to as the Commission)
Table 1 Eastern Mediterranean region: Countries, adolescent population and socioeconomic development, 1990–2015 (World Bank, Global
Burden of Disease Study 2015, Eastern Mediterranean Countries, 1990–2015)
Country Proportion of country population aged
10–24 year in % (n, number of
adolescents in each country)
Proportion of the
EMR adolescent
population (%)
GDP per capita
($US)
Socio-demographic index (SDI)
1990 2015 SDI level
Afghanistan 34.8% (11,356,556) 6.2 594.3 0.1440 0.2888 Low
Bahrain 21.7% (296,971) 0.2 22,600.2 0.5969 0.7764 High-middle
Djibouti 30.5% (271,064) 0.1 1945.1 0.3228 0.4615 Low-middle
Egypt 26.9% (24,492,800) 13.3 3614.7 0.4409 0.6191 Middle
Iran 22.8% (17,992,150) 9.8 – 0.4600 0.7154 High-middle
Iraq 31.2% (11,348,292) 6.2 4943.8 0.3997 0.5756 Middle
Jordan 29.9% (2,263,213) 1.2 4940.0 0.4967 0.6949 High-middle
Kuwait 19.1% (745,077) 0.4 29,300.6 0.6911 0.8624 High
Lebanon 28.5% (1,643,663) 0.9 8047.6 0.5698 0.7547 High-middle
Libya 25.0% (1,574,514) 0.9 – 0.4747 0.6430 Middle
Morocco 26.0% (8,932,361) 4.8 2878.2 0.3347 0.4959 Low-middle
Oman 21.4% (960,174) 0.5 15,550.7 0.4089 0.7301 High-middle
Pakistan 30.2% (57,088,761) 31 1434.7 0.2786 0.4676 Low-middle
Palestine 33.6% (1,569,806) 0.9 – 0.4229 0.5670 Middle
Qatar 19.3% (429,261) 0.2 73,653.4 0.6162 0.8045 High-middle
Saudi Arabia 24.4% (7,683,094) 4.2 20,481.7 0.5245 0.7593 High-middle
Somalia 32.7% (3,545,571) 1.9 549.3 0.1158 0.1506 Low
Sudan 32.1% (12,950,382) 7.0 2414.7 0.2667 0.4282 Low-middle
Syria 32.4% (6,032,616) 3.3 – 0.3881 0.5790 Middle
Tunisia 22.6% (2,546,994) 1.4 3872.5 0.4503 0.6515 Middle
United Arab Emirates 16.6% (1,516,072) 0.8 40,438.8 0.6324 0.8747 High
Yemen 34.2% (9,191,689) 5.0 1406.3 0.1329 0.4080 Low-middle
Total 28.4% (184,431,081) 100 – – – –
This table details the 22 countries in the East Mediterranean region. It provides the population of adolescents and contribution of each country to
the total adolescent population in the Eastern Mediterranean Region. It also provides the overall country-level GDP in 2015 and SDI in 1990 and
2015. Dashes indicate data are unavailable
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(Patton et al. 2016). Health needs included: health out-
comes (mortality, non-fatal diseases, and injuries); health
risks (behaviors and states that carry risk for poor health in
and beyond adolescence); and determinants of health (such
as education and employment). Adolescence was defined
as 10–24 years, as these years encompass the important
biological, neurocognitive, and social role transitions that
typically define adolescence (Mokdad et al. 2016b; Patton
et al. 2016; Sawyer et al. 2012). Where possible, we report
age-disaggregated data for young adolescents
(10–14 years), older adolescents (15–19 years), and young
adults (20–24 years) (Patton et al. 2016).
Data are drawn from the Global Burden of Disease
Study 2015 (GBD 2015) as this provides a complete set of
comparable health estimates for 195 countries, including
all those in the EMR. Methods are described in detail
elsewhere (GBD DALYs Hale Collaborators 2016; GBD
Disease Injury Incidence and Prevalence Collaborators
2016; GBD Mortality and Causes of Death Collaborators
2016; GBD SDG Collaborators 2016), but briefly, GBD
2015 includes a comprehensive and systematic analysis of
249 causes of death, 310 causes of disease and injury, and
79 behavioral and environmental health risks. GBD 2015
has four levels of causes that are mutually exclusive. Level
one has three causes: type I conditions (communicable,
maternal, neonatal, and nutritional disorders); non-com-
municable diseases; and injuries. Level two has 21 causes,
while levels three and four consist of all disaggregated
causes. For this analysis we report causes at level four.
GBD is based on the best available primary data and
employs a series of disease models to harmonize health
estimates and fill data gaps. Each step of the estimation
process of GBD 2015 has been documented, as well as data
sources, in accordance with Guidelines for Accurate and
Transparent Health Estimates Reporting (GATHER). For
this analysis, we accessed data in 5-year age bands, for
males and females, from 1990 to 2015 in 5-year time slices.
Mortality is reported as all-cause and cause-specific
rates per 100,000 (GBD Mortality and Causes of Death
Collaborators 2016). Non-fatal diseases and injuries are
reported as years lived with disability (YLDs), a metric
which incorporates prevalence of disease, duration, and its
severity (using disease weights) (GBD Disease Injury
Incidence and Prevalence Collaborators 2016). As a sum-
mary measure of population health, we also report dis-
ability-adjusted life-years (DALYs), the sum of years of
healthy life lost due to premature mortality (YLLs), and
years of life lived with disability (YLDs) (GBD DALYs
Hale Collaborators 2016). For these estimates, we report
95% uncertainty estimates, which are distinct from confi-
dence intervals in that they represent uncertainty derived
from sampling, model estimation, and model specification
(GBD DALYs Hale Collaborators 2016).
In addition to region-level estimates, we also report
country-specific DALY estimates and the prevalence of
three key health risks and four determinants (aligned with
the conceptual framework from the Commission and data
availability) to help prioritize country-specific actions
(Patton et al. 2016). Data for health risks were sourced
from GBD 2015. Tobacco smoking was defined as current
daily smoked tobacco use (GBD Tobacco Collaborators
2017). Overweight was defined using the International
Obesity Task Force age and gender specific cut-offs,
equivalent to BMI C25 kg/m2 at age 18 (Cole and Lobstein
2012). This definition includes those who are obese. Binge
drinking was defined as having consumed 60 grams of
alcohol on a single occasion for males and 48 grams of
alcohol on a single occasion for females in the last
12 months. With respect to determinants, adolescent fer-
tility rate (live births per 1000 15- to 19-year-old females)
and mean years of educational attainment for 15- to
24-year olds were sourced from GBD 2015 (GBD SDG
Collaborators 2016). Unmet need for contraception (15- to
24-year-old females currently married or in union and not
wanting to become pregnant within the next two years, who
report not using any method of contraception) was sourced
from a review DHS and MICS surveys available in the
EMR (data were collected from 2009 to 2014) (Patton et al.
2016). Youth unemployment data, defined as the percent-
age of 15- to 24-year olds without work but available for
and seeking employment, were obtained from the Inter-
national Labor Organization modeled estimates for 2013
(Patton et al. 2016).
We reported observed estimates for the region. We
additionally report expected DALYs for each country
based on the level of socioeconomic development.
Expected DALYs were estimated using the Socio-demo-
graphic Index (SDI) which is based on income per capita,
average educational attainment for ages 15 or older, and
the total fertility rate (GBD SDG Collaborators 2016). SDI
is reported as a continuous variable from 0 (lowest) to 1
(highest), and as quintiles, as shown in Table 1. GBD 2015
has estimated the relationship between SDI and each cause
of DALYs using spline regressions, with these regressions
then used to estimate expected DALYs at each level of SDI
(GBD DALYs Hale Collaborators 2016).
Results
Mortality
All-cause mortality rates for adolescents in the EMR ran-
ged from 63.3 per 100,000 for females aged 10–14 years to
253.2 per 100,000 for males aged 20–24 years in 2015 (e-
Figure 1, panel A). Males had a higher overall mortality
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rate than females. The risk of mortality for males aged
15–24 years had increased over recent years compared to
what was otherwise an overall trend of reduction in mor-
tality. Table 2 details the leading causes of mortality by
sex. The most striking transition in mortality cause over
time was the reduction in deaths due to natural disaster and
communicable diseases, and the emergence of mortality
due to injuries (especially in the context of war) and NCDs.
In 1990 and 2005 natural disaster ranked as a leading cause
of mortality for adolescents, whereas in 2015 it was no
longer a leading cause of death for adolescents. In 2015,
war and legal interventions (law enforcement) was the
leading cause of death for adolescents of both sexes, rep-
resenting 27.7% (14.2–38.4) of deaths amongst male 20- to
24-year olds and 7.2% (3.1–10.9) amongst female 20- to
24-year olds. For males, injuries (unintentional injuries,
self-harm and violence) were the predominant causes of
mortality across adolescence, and communicable diseases
an important cause for 10- to 14-year olds. The leading
cause of mortality for females included injuries; however,
communicable and maternal conditions were also leading
causes, with NCDs emerging as an important cause
amongst older female adolescents.
YLDs
All-cause YLD rates are similar for males and females in
the region, and have seen little improvement since 1990 (e-
Figure 1 panel B). The leading causes of YLDs are detailed
in Table 3. While the burden of some communicable,
maternal, and nutritional disorders has declined, this has
largely been offset by an increase in disability due to injury
among males and lack of reduction in YLDs from non-
communicable disease. From 1990 to 2015, iron deficiency
anemia was the leading cause of disability for females aged
10–14 and 15–19 years, and for males aged 10–14 years.
NCDs, particularly mental health disorders, migraine,
asthma, skin conditions, and musculoskeletal disorders,
were major contributors to YLDs for both sexes in 2015.
Major depression emerged as the leading cause of mor-
bidity amongst males aged 15–19 (7.0%, uncertainty
4.6–9.9) and 20–24 years (8.0%, uncertainty 5.1–11.7) and
for females aged 20–24 years (9.1%, uncertainty 6.2–12.4)
in 2015. Among older males, opioid use disorders and war
were also important causes of disability.
DALYs
All-cause DALY rates have declined for females of all ages
and 10- to 14-year-old males in the region (e-Figure 1,
panel c), largely due to a reduction of communicable,
maternal, and nutritional diseases. DALY rates have
increased for males aged 15–19 and 20–24 since 1990,
largely due to an increased burden of injury. The leading
causes of DALYs by age and sex are provided in Table 4.
For females, type 1 conditions (nutritional disorders,
communicable disease, and maternal disorders) remain
important causes of DALYs. However, non-communicable
diseases (mental health disorders, migraine, skin condi-
tions, and musculoskeletal disorders) account for more than
half of the total disease burden. For males, injuries due to
conflict, transport, and other unintentional injuries are the
leading causes of DALYs, particularly amongst 15- to
24-year olds.
There was considerable variation in all-cause and cause-
specific DALY rates across countries in the region (e-
Figure 2, panels A–C). In all countries in the region,
DALY rates are highest among males, and higher among
20- to 24-year olds than other ages in males and females.
The highest DALY rates were in countries most affected by
recent conflict or insecurity and/or those with the lowest
SDI, such as Pakistan (17,483 per 100,000 10–24 years in
2015), Somalia (27,716 DALYs per 100,000 10- to 24-year
olds in 2015), Afghanistan (32,068 per 100,000 10- to
24-year olds in 2015) and Syria (33,452 per 100,000 10- to
24-year olds in 2015), with 10- to 24-year olds globally
having a DALY rate of 14,557 per 100,000 in 2015. In
these countries, injury, particularly due to war and legal
intervention was a major contributor to DALYs, particu-
larly amongst males. For example, in Syria over 70% of
DALYs to 10–24 year olds were due to injury, with males
aged 20–24 experiencing the largest burden. A number of
these countries also experience a high burden of nutritional
disorders and communicable disease among younger ado-
lescents, in addition to a substantial burden of maternal
health problems. Countries with a higher SDI and those
less affected by conflict experienced a lower burden of
poor health. In these settings DALYs were mostly due to
NCDs including mental health disorders, skin conditions,
asthma, migraine, and musculoskeletal disorders.
The three countries that had the largest populations of
adolescents in the EMR (Pakistan, Iran, and Egypt) had
very different disease burdens. Egypt (12,418 DALYs per
100,000 10- to 24-year olds in 2015) and Iran (12,624
DALYs per 100,000 10- to 24-year olds in 2015) has
similar low rates of DALYs; however, Iran had a higher
burden due to injury (3361 per 100,000 in Iran compared to
1938 per 100,000 in Egypt). Pakistan had a high burden of
injury (3367 per 100,000) but more so type I conditions
(5252 per 100,000).
e-Figure 2, panels D–F shows the expected DALYs in
each country based on the SDI. The most striking finding
is that with the reduction of DALYs due to war (which
is not expected based on development), there remains a
very large burden of poor health for adolescents in the
EMR.
GBD 2015 Eastern Mediterranean Region Adolescent Health Collaborators, A. H. Mokdad
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Health risks and determinants
The prevalence of selected health risks is provided in
e-Figure 3. The prevalence of overweight and obesity was
highest among countries with a higher SDI in the region,
and was generally similar for males and females. Rates of
daily tobacco smoking among males aged 10–24 years
ranged from 1.9% in Sudan to 18% in Kuwait, but were
less than 5% for females in the region. Similarly, the
prevalence of binge drinking was higher among males than
females at all ages, but was less than 10% for both sexes in
most EMR countries. Unmet need for contraception was
high among the 11 countries for which data are available
(e-Figure 4). More than one third of females who are
married or in union have unmet need for contraception in
Pakistan, Djibouti, Somalia, Sudan, and Yemen. These
countries also have among the highest rates of adolescent
birth rates in the region, adolescent fertility the greatest in
Somalia (114.7 live births per 1000 females aged 15–19 in
2015). There was also great variation in educational
attainment in the EMR region. Low-SDI countries affected
by protracted insecurity and conflict have the lowest mean
number of years of completed education, most notably for
females. Rates of unemployment among 15- to 24-year
olds also vary considerably, and were generally higher for
females than males.
Discussion
This study is the first systematic analysis of adolescent
health in the EMR. The findings suggest dramatic shifts in
the health of adolescents living in the EMR over the past
25 years. Communicable diseases and the health conse-
quences of natural disasters have reduced substantially, but
these gains have largely been offset by war and the
emergence of NCDs including mental health disorders,
unintentional injury, and self-harm. Indeed, adolescents
living in Syria, Afghanistan, and Somalia experience
amongst the largest burdens of disease and injury of all
adolescents globally (Patton et al. 2016). Even with the
return of peace and security to this region, adolescents will
have a persisting poor health profile that will pose a barrier
to socioeconomic growth and development of the EMR
(The World Bank 2006).
The substantial reductions in mortality and morbidity
due to communicable disease, maternal disorders, and
natural disasters in the EMR are likely the result of
socioeconomic growth and development, educational par-
ticipation, and interventions through the health system.
Recent wars and civil conflict, however, threaten the
foundations on which these gains were made, with the risk
of resurgence of many of these conditions. This is inT
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addition to the growing burden of NCDs and injuries.
Renewed efforts to consolidate gains made in communi-
cable disease and maternal health will be required. The
Lancet Commission described the benefits that can accrue
from investments in adolescence. Without these invest-
ments, the EMR region risks poor health across adoles-
cence, adulthood, and in the next generation (Patton et al.
2016).
War and legal interventions (deaths due to law
enforcement, regardless of their legality) were the leading
causes of mortality for adolescents aged 10–24 years of
both genders in the EMR. While not all countries in the
EMR are affected by conflict, the magnitude of mortality in
those countries that are affected signifies this as a priority
for the region. It should also be noted, however, that at a
population level (all ages combined), war and legal inter-
vention is only the fifth leading cause of mortality in the
EMR (GBD 2015 Eastern Mediterranean Region Collab-
orators and Mokdad 2017). This may reflect competing
causes of mortality at other ages, or it may signify that war
and legal interventions disproportionately affect adoles-
cents, particularly 20- to 24-year-old males. In addition to
the physical injuries and disability that accompany conflict,
violence and trauma at this critical developmental stage
carry a risk of persisting effects on future mental health and
well-being. War and conflict are also likely to result in
disruption to quality education, social infrastructure, and
community development, which have profound implica-
tions for health and well-being across the course of one’s
life. This may explain why expected DALYs in countries
which have experienced large burdens of conflict remain
high.
In addition to the health status of adolescents, we
explored the burden of risk behavior for future health.
Tobacco smoking and high body mass were common risks
where interventions during adolescence have the potential
to avert later ischemic heart disease, the leading cause of
poor health in the region. Of note, estimates of tobacco
smoking reported here do not include Sisha smoking which
is prevalent in some countries of the EMR and harmful
(Maziak et al. 2004). Low rates of education completion in
many countries including Afghanistan, Somalia, and
Yemen are a major obstacle to growth and future prosperity
of this region. High rates of adolescent pregnancy represent
an important target for action to improve health and life
opportunities for girls and young women. Unmet need for
contraception is very high, and is likely to also signify high
rates of unmet need for other essential health interventions,
particularly for culturally sensitive needs such as sexually
transmitted infections and mental health. Given adolescents
face barriers in accessing health facilities, there is a need to
explore other approaches such as community-based deliv-
ery or school health services (Tylee et al. 2007). There isT
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also the need for community-based interventions to address
some of the sociocultural barriers that contribute to high
unmet need for interventions relating to sexual and repro-
ductive health (Patton et al. 2016).
As over half of the region’s adolescents live in Pakistan,
Iran, and Egypt (Table 1), a regional response must pri-
oritize these three countries. This is challenging, however,
given the different stages of development and the very
different needs of adolescents across these countries. For
example, the burden of disease experienced by adolescents
in Egypt is predominantly caused by NCDs, which require
interventions to address the burden of chronic illness and
health risks such as tobacco smoking and obesity (Patton
et al. 2016). In addition to NCDs, adolescents living in Iran
are burdened by injury (particularly relating to transport
injury) which requires a suite of inter-sectoral actions
(WHO 2017a). Adolescents living in Pakistan experience a
‘‘multi-burden’’ profile of disease, with a large burden of
communicable, nutritional, and reproductive poor health in
addition to NCDs and injury. However, in countries such as
Afghanistan, Somalia, and Sudan, adolescents represent
almost a third of the country-level population and experi-
ence a particularly large and complex burden of disease. It
is, therefore, important not to neglect their health needs (or
indeed other countries in the EMR).
What this analysis highlights is that unintentional injury,
mental health, sexual health, substance use, and self-harm
are increasingly important health issues for adolescents in
the EMR. While these are health issues common to ado-
lescents globally (Patton et al. 2016), they have typically
sat at the margins (if at all) of policy, program, and data
collection in EMR, given religious and cultural sensitivi-
ties. These findings highlight the need to better align health
actions, including data monitoring of sensitive health out-
comes, including risks, in this region to these needs.
Our analysis has important limitations. Firstly, there is
considerable variation in the availability and quality of
primary data for adolescent health. This includes paucity of
data for some age groups (particularly 10- to 14-year olds),
and for many health outcomes and risks of importance
during these important developmental years (Mokdad et al.
2016b; Patton et al. 2012; The Global Burden of Disease
Child and Adoelscent Health Collaboration 2017). Avail-
ability of timely, quality data is likely to be particularly
poor in settings of conflict and insecurity, which affects
many countries in this region. The poor quality of primary
data necessitated the use of modeled estimates, and some
of these modeled estimates may have over- or under-esti-
mated the true burden. For example, ischemic heart disease
was found to be a leading cause of mortality amongst males
aged 20–24 years, a cause of death more commonly asso-
ciated with adulthood. Premature death due to cardiovas-
cular disease is possible during adolescence, particularly inT
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the context of adolescent obesity which is prevalent in
EMR (Franks et al. 2010). This finding may also be an
artifact of disease modeling, as ischemic heart disease is
the leading cause of mortality in the EMR, and these deaths
are modeled to have their onset after 0.1 years of age
(GBD 2015 Eastern Mediterranean Region Cardiovascular
Disease Collaborators and Mokda 2017; GBD 2015 East-
ern Mediterranean Region Collaborators and Mokdad
2017; GBD Mortality and Causes of Death Collaborators
2016). The findings of this study should therefore be
interpreted as not only indicating priority areas to address
adolescent health in the EMR, but also where data col-
lection efforts should focus. A further limitation is that the
broader impacts of armed conflict on adolescent health and
well-being, beyond mortality, are not captured by the 2015
GBD study. These include participation in education and
employment, as well as the impacts of trauma on adoles-
cent development and wellbeing. Additionally, some
important health issues such as female genital cut-
ting/mutilation (common in countries such as Somalia) are
not included in GBD 2015 (UNICEF 2016a).
There are several regional efforts that may facilitate
addressing the needs of adolescents in the EMR. For
example, a coalition of youth advocates for health in the
EMR has been established (Alaovie et al. 2017). There is a
joint UN strategy for youth in the region (IATTTYP 2015).
UNICEF has also published guidance around good practice
with adolescent and youth programming (UNICEF 2016b).
This study compliments these efforts, and helps to inform
some priority areas for health. For conflict-affected coun-
tries, the focus must clearly be on the return of peace and
stability and the rebuilding of health, education, and social
systems. In doing so, it is important to design services that
meet the needs of adolescents. For countries not affected
by conflict, health actions include the need to re-orientate
health systems to focus on prevention and the growing
burden of NCDs. This needs to extend to inter-sectoral
actions to address the broader determinants of NCDs and
injuries. Without urgent action, there is a risk that profiles
of adolescent health will continue to deteriorate with
consequences for future population health and wellbeing,
productivity, and ultimately the stability of civil society.
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